Chinese financing shapes pharma global competition

A recent survey has revealed that China leads in drug development and supply chain management, establishing itself as a pioneer in these areas. Meanwhile, the United States remains ahead in technology transfer, capital flows, and marketing, despite its market share in drug development programs declining to around 37% in 2024 from 48% in 2015. China's share of the global pharmaceutical market has surpassed 32%, up from less than 8% in 2015, prompting American concerns about potential challenges to U.S. dominance in the biotechnology industry.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل